Balaji Amines Ltd

Balaji Amines Summary Chart Analysis Peers Quarters Profit & Loss Balance Sheet Cash Flow Ratios Investors Documents

Balaji Amines Ltd

₹ 1,839 0.75%
02 Jul - close price
balajiamines.com BSE: 530999 NSE: BALAMINES
About

Balaji Amines Ltd specialises in manufacturing Methylamines, Ethylamines, Derivatives of specialty chemicals and Pharma Excipients. These have been the main products, it also have facilities for the manufacturing of derivatives, which are down-stream products for various pharma/pesticide industries apart from user specific requirements. It is one of the largest manufacturers of aliphatic amines in India. [1]

Key Points

Market Leadership
The company is the largest manufacturer of aliphatic amines and their derivatives in India and the sole producer of a few specialty chemicals. [1]

Website BSE NSE
  • Market Cap ₹ 5,947 Cr.
  • Current Price ₹ 1,839
  • High / Low ₹ 2,550 / 1,112
  • Stock P/E 37.8
  • Book Value ₹ 569
  • Dividend Yield 0.60 %
  • ROCE 11.0 %
  • ROE 8.83 %
  • Face Value ₹ 2.00
Edit ratios

Pros

  • Company has reduced debt.
  • Company is almost debt free.
  • Promoter holding has increased by 0.92% over last quarter.

Cons

  • The company has delivered a poor sales growth of 8.37% over past five years.
  • Dividend payout has been low at 9.12% of profits over last 3 years

* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.

Peer comparison

Commodities Chemicals Chemicals & Petrochemicals Specialty Chemicals

Part of BSE SmallCap BSE Allcap BSE Commodities Nifty Microcap 250 Nifty Total Market

Edit Columns
Loading peers table ...

Quarterly Results

Consolidated Figures in Rs. Crores / View Standalone

Mar 2022 Jun 2022 Sep 2022 Dec 2022 Mar 2023 Jun 2023 Sep 2023 Dec 2023 Mar 2024 Jun 2024 Sep 2024 Dec 2024 Mar 2025
780 670 628 586 471 464 381 383 414 385 347 313 353
584 455 455 458 378 366 327 309 316 319 286 267 293
Operating Profit 196 215 173 128 93 98 54 74 98 66 61 46 60
OPM % 25% 32% 27% 22% 20% 21% 14% 19% 24% 17% 17% 15% 17%
5 5 3 3 6 6 7 8 9 8 9 8 8
Interest 7 3 2 3 3 2 2 2 1 1 1 1 1
Depreciation 11 11 11 12 11 11 11 11 12 12 12 12 13
Profit before tax 183 205 162 115 85 90 48 70 93 62 57 41 54
Tax % 29% 28% 27% 27% 35% 25% 24% 21% 22% 26% 27% 24% 25%
131 148 119 84 55 68 36 56 72 46 41 31 40
EPS in Rs 33.55 37.95 28.57 19.31 14.63 16.27 10.71 15.24 21.00 13.36 12.65 10.24 12.36
Raw PDF

Profit & Loss

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
608 616 640 668 858 940 935 1,308 2,314 2,346 1,634 1,397
517 515 514 519 676 747 754 935 1,691 1,736 1,310 1,165
Operating Profit 91 102 127 149 182 193 181 373 623 609 324 232
OPM % 15% 17% 20% 22% 21% 21% 19% 29% 27% 26% 20% 17%
3 4 3 9 12 4 5 6 15 15 30 33
Interest 32 35 22 13 9 13 23 18 17 12 6 4
Depreciation 16 20 19 20 19 20 32 34 42 46 45 48
Profit before tax 46 51 88 126 166 165 131 327 578 567 302 213
Tax % 27% 35% 34% 34% 32% 29% 26% 25% 28% 28% 23% 26%
34 33 58 82 113 117 97 243 418 406 232 159
EPS in Rs 10.34 10.25 17.78 25.42 34.93 36.27 32.34 73.51 113.71 100.47 63.22 48.62
Dividend Payout % 10% 12% 11% 9% 7% 8% 10% 5% 5% 10% 17% 0%
Compounded Sales Growth
10 Years: 9%
5 Years: 8%
3 Years: -15%
TTM: -14%
Compounded Profit Growth
10 Years: 17%
5 Years: 10%
3 Years: -25%
TTM: -23%
Stock Price CAGR
10 Years: 32%
5 Years: 27%
3 Years: -14%
1 Year: -24%
Return on Equity
10 Years: 20%
5 Years: 19%
3 Years: 14%
Last Year: 9%

Balance Sheet

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Equity Capital 6 6 6 6 6 6 6 6 6 6 6 6
Reserves 195 221 274 356 461 568 652 888 1,243 1,548 1,715 1,839
262 256 173 105 152 227 260 127 101 58 20 11
158 139 152 168 229 244 195 289 395 351 405 396
Total Liabilities 620 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146 2,252
325 341 341 325 316 320 573 543 681 780 896 1,006
CWIP 8 3 16 25 123 269 46 173 141 113 205 234
Investments 20 0 0 0 0 0 48 0 0 73 0 0
267 278 248 284 409 457 446 594 923 996 1,046 1,011
Total Assets 620 623 605 635 848 1,046 1,113 1,310 1,745 1,963 2,146 2,252

Cash Flows

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
111 56 85 60 140 94 144 110 220 354 224 255
-50 -4 -29 -10 -135 -119 -130 -62 -147 -210 -164 -139
-53 -55 -54 -55 16 21 -26 -37 -57 -81 -75 -49
Net Cash Flow 7 -3 2 -5 21 -4 -12 11 16 63 -15 68

Ratios

Consolidated Figures in Rs. Crores / View Standalone

Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024 Mar 2025
Debtor Days 79 71 71 68 73 65 81 85 93 59 71 72
Inventory Days 87 114 80 106 70 116 77 64 66 89 116 128
Days Payable 83 48 58 55 56 60 42 44 54 18 31 32
Cash Conversion Cycle 83 136 93 119 87 120 116 104 105 129 156 168
Working Capital Days 67 95 70 78 74 89 102 91 94 94 116 122
ROCE % 18% 18% 23% 30% 32% 24% 18% 35% 49% 36% 17% 11%

Shareholding Pattern

Numbers in percentages

2 Recently
Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024Sep 2024Dec 2024Mar 2025
53.70% 53.70% 53.70% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 53.71% 54.62%
4.51% 4.55% 4.39% 4.45% 4.55% 4.52% 4.58% 4.92% 5.05% 5.27% 5.16% 5.09%
0.18% 0.24% 0.37% 0.34% 0.18% 0.90% 1.43% 1.48% 1.59% 1.79% 1.66% 1.48%
41.61% 41.51% 41.53% 41.50% 41.57% 40.88% 40.31% 39.91% 39.67% 39.23% 39.46% 38.83%
No. of Shareholders 1,19,6511,20,7851,29,7021,36,6441,40,9571,44,9901,41,4171,38,0171,32,4281,29,1601,29,3611,27,442

* The classifications might have changed from Sep'2022 onwards. The new XBRL format added more details from Sep'22 onwards.

Classifications such as banks and foreign portfolio investors were not available earlier. The sudden changes in FII or DII can be because of these changes.

Click on the line-items to see the names of individual entities.

Documents

Announcements

Annual reports

Credit ratings

Concalls